Revenue
2011
2013
2014
2016
2022
2023
2024
2025
Lunai Bioworks Inc. (LNAI)
Price$2.39Cached quote
Net income
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2013
2018
2019
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — | — | — | $42,769 | — | $0 | $32,768 | — | $0 |
| Gross profit | — | $0 | $0 | — | — | — | — | — | — | $37,494 | −$65,932 | −$295,661 | −$76,531 | — | — |
| Gross margin | — | — | — | — | — | — | — | — | — | 87.67% | — | — | −233.55% | — | — |
| Research & development | $537,428 | $2.7M | $4.2M | $8.4M | $15.7M | $4.7M | $2.5M | $616,961 | $62,763 | $804,188 | $1.6M | — | — | — | — |
| Operating expenses | $189.0M | $81.6M | $38.6M | $116.1M | $23.4M | $11.9M | $11.0M | $5.3M | $2.4M | $2.2M | $2.7M | $2.1M | $1.7M | — | — |
| Operating income | −$189.0M | −$81.6M | −$38.6M | −$116.1M | −$23.4M | −$11.9M | −$11.0M | −$5.3M | −$2.4M | −$2.1M | −$2.7M | −$2.4M | −$1.7M | — | — |
| Operating margin | — | — | — | — | — | — | — | — | — | −4,959.04% | — | — | −5,306.85% | — | — |
| EBITDA | −$188.8M | −$81.5M | −$38.4M | −$116.0M | −$23.3M | −$11.8M | −$10.9M | −$5.3M | −$2.4M | −$2.1M | −$2.7M | −$2.4M | −$1.7M | — | — |
| EBITDA margin | — | — | — | — | — | — | — | — | — | −4,894.98% | — | — | −5,189.97% | — | — |
| Net income | −$178.0M | −$88.4M | −$39.7M | −$113.4M | −$26.7M | −$11.4M | −$18.0M | −$6.3M | −$2.1M | −$1.7M | −$2.7M | −$2.4M | −$2.1M | −$37,589 | −$29,945 |
| Net profit margin | — | — | — | — | — | — | — | — | — | −4,057.24% | — | — | −6,553.23% | — | — |
| Basic EPSper basic share | -$10.80 | -$9.10 | -$7.10 | -$21.60 | -$5.70 | -$2.50 | -$4.80 | -$2.90 | -$1.70 | -$1.80 | -$2.80 | -$3.20 | -$4.00 | — | $0.00 |
| Diluted EPSper diluted share | -$10.80 | -$9.10 | -$7.10 | -$21.60 | -$5.70 | -$2.50 | -$4.80 | -$2.90 | -$1.70 | -$1.80 | -$2.80 | -$3.20 | -$4.00 | — | $0.00 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Brink Karen | 25.37M |
William Anderson Wittekind | 18.13M |
Weinstein David Hershel | 250K |
van Tilburg Maurice | 250K |
Miller Avram | 166.67K |
Ground Swell Capital, LLC | 53.21K |
GEODE CAPITAL MANAGEMENT, LLC | 24.16K |
JANE STREET GROUP, LLC | 23.68K |
VANGUARD CAPITAL MANAGEMENT LLC | 16.08K |
BlackRock, Inc. | 15.91K |
Virtu Financial LLC | 12.86K |
VANGUARD FIDUCIARY TRUST CO | 8.64K |
ROYAL BANK OF CANADA | 1.69K |
Tower Research Capital LLC (TRC) | 1.41K |
GROUP ONE TRADING LLC | 544 |
MORGAN STANLEY | 326 |
COMPASS FINANCIAL MANAGEMENT LLC | 125 |
BNP PARIBAS FINANCIAL MARKETS | 24 |
JPMORGAN CHASE & CO | 6 |
DEUTSCHE BANK AG\ | 1 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4/A ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 29, 2024Form 4 | William Anderson WittekindTenPercentOwner | SellCommon Stock · indirect | 1.1K | $1.30 | $1.4K | 840.3K |
| Jul 17, 2024Form 4 | William Anderson WittekindTenPercentOwner | SellCommon Stock · indirect | 16.4K | $1.46 | $23.9K | 841.4K |
| Jul 15, 2024Form 4 | William Anderson WittekindTenPercentOwner | SellCommon Stock · indirect | 22.0K | $1.41 | $31.0K | 875.8K |
| Jul 11, 2024Form 4 | William Anderson WittekindTenPercentOwner | SellCommon Stock · indirect | 14.9K | $1.51 | $22.5K | 897.7K |
| Jul 10, 2024Form 4 | William Anderson WittekindTenPercentOwner | SellCommon Stock · indirect | 75.0K | $1.51 | $113.3K | 894.6K |